These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3915889)

  • 21. Efficacy and tolerability of tenoxicam--an overview.
    Vischer TL
    Eur J Rheumatol Inflamm; 1987; 9(2):51-7. PubMed ID: 3329109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term treatment with tenoxicam in rheumatoid arthritis.
    Orozco-Alcalá JJ; Barrera-Tenorio EF
    Eur J Rheumatol Inflamm; 1987; 9(2):118-21. PubMed ID: 3329102
    [No Abstract]   [Full Text] [Related]  

  • 23. Piroxicam suppositories for osteoarthritis and rheumatoid arthritis: an open multicentre study in 116 patients.
    Heynen G; Dessain P
    Eur J Rheumatol Inflamm; 1983; 6(1):134-8. PubMed ID: 6345164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of tenoxicam in patients with acute gouty arthritis.
    Valdés EF
    Eur J Rheumatol Inflamm; 1987; 9(2):133-6. PubMed ID: 3329106
    [No Abstract]   [Full Text] [Related]  

  • 25. [Chronotherapy of tenoxicam].
    Reinberg A; Manfredi R; Kahn MF; Chaouat D; Chaouat Y; Delcambre B; Le Goff P; Maugars Y; Valat JP
    Therapie; 1991; 46(2):101-8. PubMed ID: 2053087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind study of tenoxicam suppositories versus piroxicam suppositories in acute non-articular rheumatism.
    Labrousse CL; Munoz M; Kramer F
    Scand J Rheumatol Suppl; 1989; 80():62-6. PubMed ID: 2688080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative study of the efficacy and safety of aceclofenac and tenoxicam in rheumatoid arthritis.
    Perez-Ruiz F; Alonso-Ruiz A; Ansoleaga JJ
    Clin Rheumatol; 1996 Sep; 15(5):473-7. PubMed ID: 8894360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Dynamics of the joint pains at night in rheumatoid arthritis and arthroses treated with Rengasil and piroxicam].
    Malaia LT; Liashenko MM; Brigidina VIa
    Farmakol Toksikol; 1986; 49(6):83-7. PubMed ID: 3545900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [FDDF (fast dissolving dosage form) piroxicam for sublingual administration in the treatment of rheumatoid arthritis].
    Montecucco C; Caporali R; Ronchetti A; Rossi S; Comaschi E
    Minerva Med; 1994 Dec; 85(12):633-8. PubMed ID: 7854556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the efficacy and safety of etodolac and piroxicam in patients with rheumatoid arthritis. Etodolac Study 326 Rheumatoid Arthritis Investigators Group.
    Lightfoot R
    J Rheumatol Suppl; 1997 Feb; 47():10-6. PubMed ID: 9035015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Symptomatic long-term treatment of arthrosis with tenoxicam.
    Gross W
    Eur J Rheumatol Inflamm; 1987; 9(2):98-101. PubMed ID: 3329118
    [No Abstract]   [Full Text] [Related]  

  • 32. The efficacy of tenoxicam in patients suffering from rheumatoid arthritis (including assessments of quantified articular scintigraphic data).
    Berg D; Scholz HJ
    Scand J Rheumatol Suppl; 1989; 80():41-7. PubMed ID: 2556792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rheumatic diseases--clinical experience with piroxicam-beta-cyclodextrin.
    Serni U
    Eur J Rheumatol Inflamm; 1993; 12(4):47-54. PubMed ID: 7805704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-steroidal anti-inflammatory drug-induced gastropathy: a comparative endoscopic and histopathological evaluation of the effects of tenoxicam and diclofenac.
    al-Quorain AA; Satti MB; Marwah S; al-Nahdi M; al-Habdan I
    J Int Med Res; 1993; 21(2):89-97. PubMed ID: 8243794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical experience with tenoxicam: a review.
    Bird HA
    Scand J Rheumatol Suppl; 1987; 65():102-6. PubMed ID: 3317799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double-blind comparison of the efficacy and safety of etodolac SR 600 mg u.i.d. and of tenoxicam 20 mg u.i.d. in elderly patients with osteoarthritis of the hip and of the knee.
    Perpignano G; Bogliolo A; Puccetti L
    Int J Clin Pharmacol Res; 1994; 14(5-6):203-16. PubMed ID: 7672877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Long term study on the efficacy and safety of lornoxicam in rheumatoid arthritis].
    Frizziero L; Focherini MC; Valentini M; Reta M; Rocchi P
    Minerva Med; 2002 Aug; 93(4):315-20. PubMed ID: 12207202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A double-blind parallel study of tenoxicam and piroxicam in patients with osteoarthrosis.
    Bird HA; Hill J; Dixon JS; Looi D; Wright V
    Eur J Rheumatol Inflamm; 1985; 8(1):53-9. PubMed ID: 3915888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tenoxicam. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    Gonzalez JP; Todd PA
    Drugs; 1987 Sep; 34(3):289-310. PubMed ID: 3315620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Tenoxicam, a new long-acting non-steroidal anti-inflammatory drug. A placebo-controlled multicenter study].
    Gallo C; Vighi G; Schroeder J
    Clin Ter; 1987 Mar; 120(5):405-14. PubMed ID: 2953540
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.